Herrera GÁ, Ortega GC, Luna-Ortiz K, De León ZL

Language: Spanish
References: 15
Page: 127-131
PDF size: 95.04 Kb.

ABSTRACT

Objective: To demonstrate the feasibility, morbidity, and therapeutic benefit of the resection of large vessels’ residual tumor.
Setting: National Institute of Cancerology, Mexico.
Design: Case report.
Methods: We reviewed case histories from 2004 to 2008 during which 58 patients were susceptible to retroperitoneal lymphadenectomy after treatment with chemotherapy due to germinal non-seminomatous tumors. Three patients were candidates for resection and reconstruction of large vessels by means of a polytetrafluorethylene (PTFE) prosthesis.
Results: Mean age was of 28.5 years at the time of diagnosis. The mean average size of the tumor was of 5.75 cm. Average transoperative bleeding amounted to 500 ml. Follow-up was of 27 months after the vascular replacement. One patient died 3 days after surgery due to renal failure.
Conclusion: Aortic replacement in retroperitoneal tumors after chemotherapy should be performed in selected cases to obtain an actual benefit in survival, and it is possible to perform with low morbidity and mortality in specialized medical centers.

REFERENCES

1. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006; 367: 754-765.

2. Yoon GH, Stein JP, Skinner DG. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update. Urol Oncol 2005; 23: 168-177.

3. Siegel RJA, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.

4. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987; 316: 1435-1440.

5. Steterbertg EW, Keizer HJ, Fossâ SD, Sleijfer DT, Toner GC, Schraffordt Koops H, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995; 13: 1177-1187.

6. Fossâ SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE. Is Postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 1992; 10: 569-573.

7. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003; 21: 3310-3317.

8. Kulfarni RP, Reynolds KW, Newlands ES, Dawson PM, Makey AR, Theodorou NA, et al. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis. Br J Surg 1991; 78: 226-229.

9. Beck SD, Foster RS, Bihrle R, Ulbright T, Koch MO, Whale GR, et al. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 2002; 168: 1402-1404.

10. Donohue JP. Retroperitoneal lymphadenectomy: the anterior approach including bilateral suprarenal-hilar dissection. Urol Clin North Am 1977; 4: 509-521.

11. Beck SD, Lalka SG. Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer. J Vasc Surg 1998; 28: 808-814.

12. Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003; 169: 2126-2128.

13. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 1995; 153: 976-980.

14. Baniel J, Sella A. Complications of retroperitoneal lymph node dissection in testicular cancer: Primary and postchemotherapy. Semin Surg Oncol 1999; 17: 263-267.

15. Beck SD, Foster RS, Bihrle R, Koch MO, Wahle GR, Donohue JP. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection. J Urol 2001; 165: 1517-1520.